Update on Ozempic availability – February 2023 16 February 2023 The Therapeutic Goods Administration (TGA) has advised that limited supplies of Ozempic have now arrived in Australia. It is expected that from late next week some pharmacies will have stock. The TGA expects supply to improve over the next few weeks, however stock will remain limited for some time. Health professionals are being strongly recommended to prioritise people living with type 2 diabetes and consider alternative medicines to treat people living with obesity until stock levels approve. If you live with type 2 diabetes and were using Ozempic to manage your condition talk to your pharmacist so that they can assist you in filling your prescription when they have stock. More information is available on the TGA website: https://www.tga.gov.au/news/news/limited-ozempic-supplies-commence-distribution-australia
Media releases 6 November 2026 Diabetes Australia welcomes new oral GLP-1 treatment option for Australians Diabetes Australia welcomes the Therapeutic Goods Administration’s (TGA) recent approval of a new oral formulation of Wegovy (semaglutide) as a step forward in the treatment of obesity and related chronic conditions. Continue Reading
Media releases 15 October 2026 Resilience and strength of Nhulunbuy man recognised with Kellion Victory Medal Nhulunbuy man Gerald Buckle has been awarded a Kellion Victory Medal, marking 50 years of living with diabetes, at a ceremony alongside family and supporters in Darwin. Continue Reading
Media releases 14 August 2026 Beyond blood glucose: New national partnership to measure how Australians with diabetes are really doing For the first time, the Australian Unity Wellbeing Index will be used to build the most complete picture yet of how diabetes affects Australian’s lives beyond clinical outcomes and health system costs, thanks to a partnership between Diabetes Australia, Deakin University, and the Australian Unity Support Foundation. Continue Reading
